Cooperative interactions of PTEN deficiency and RAS activation in melanoma metastasis

Mutations of the BRAF gene in human cancer

Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002) · Nature · doi:10.1038/nature00766 · Cited by 10,674 · see citing works

<i>PTEN</i> , a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer

Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., et al. (1997) · Science · doi:10.1126/science.275.5308.1943 · Cited by 4,785 · see citing works

A System for Stable Expression of Short Interfering RNAs in Mammalian Cells

Brummelkamp, T. R., Bernards, R., & Agami, R. (2002) · Science · doi:10.1126/science.1068999 · Cited by 4,295 · see citing works

Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers

Steck, P. A., Pershouse, M. A., Jasser, S. A., Yung, W. K. A., Lin, H., Ligon, A. H., Langford, L. A., Baumgard, M. L., Hattier, T., Davis, T., et al. (1997) · Nature Genetics · doi:10.1038/ng0497-356 · Cited by 2,742 · see citing works

High frequency of BRAF mutations in nevi

Pollock, P. M., Harper, U. L., Hansen, K. S., Yudt, L. M., Stark, M., Robbins, C. M., Moses, T. Y., Hostetter, G., Wagner, U., Kakareka, J., et al. (2003) · Nature Genetics · doi:10.1038/ng1054 · Cited by 1,730 · see citing works

Role of the INK4a Locus in Tumor Suppression and Cell Mortality

Serrano, M., Lee, H.-W., Chin, L., Cordon-Cardo, C., Beach, D., & DePinho, R. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81079-x · Cited by 1,585 · see citing works

Pten is essential for embryonic development and tumour suppression

Cristofano, A. D., Pesce, B., Cordon‐Cardo, C., & Pandolfi, P. P. (1998) · Nature Genetics · doi:10.1038/1235 · Cited by 1,518 · see citing works

Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis

Cully, M., You, H., Levine, A. J., & Mak, T. W. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1819 · Cited by 1,233 · see citing works

BrafV600E cooperates with Pten loss to induce metastatic melanoma

Dankort, D., Curley, D. P., Cartlidge, R. A., Nelson, B., Karnezis, A. N., Damsky Jr, W. E., You, M. J., DePinho, R. A., McMahon, M., & Bosenberg, M. (2009) · Nature Genetics · doi:10.1038/ng.356 · Cited by 1,189 · see citing works

Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer

Wang, S., Gao, J., Lei, Q., Rozengurt, N., Pritchard, C., Jiao, J., Thomas, G. V., Li, G., Roy-Burman, P., Nelson, P. S., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00215-0 · Cited by 1,109 · see citing works

Tenets of PTEN Tumor Suppression

Salmena, L., Carracedo, A., & Pandolfi, P. P. (2008) · Cell · doi:10.1016/j.cell.2008.04.013 · Cited by 1,027 · see citing works

Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems

Podsypanina, K., Ellenson, L. H., Nemes, A., Gu, J., Tamura, M., Yamada, K. M., Cordon‐Cardo, C., Cattoretti, G., Fisher, P. E., & Parsons, R. E. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.4.1563 · Cited by 947 · see citing works

Essential role for oncogenic Ras in tumour maintenance

Chin, L., Tam, A., Pomerantz, J. H., Wong, M., Holash, J., Bardeesy, N., Shen, Q., O'Hagan, R., Pantginis, J., Zhou, H., et al. (1999) · Nature · doi:10.1038/22788 · Cited by 928 · see citing works

The Catalogue of Somatic Mutations in Cancer (COSMIC)

Forbes, S. A., Bhamra, G., Bamford, S., Dawson, E., Kok, C. Y., Clements, J., Menzies, A. H., Teague, J. W., Futreal, P. A., & Stratton, M. R. (2008) · Current Protocols in Human Genetics · doi:10.1002/0471142905.hg1011s57 · Cited by 899 · see citing works

High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice

Suzuki, A., de la Pompa, J. L., Stambolic, V., Elia, A., Sasaki, T., Barrantes, I. D. B., Ho, A., Wakeham, A. C., ltie, A., Khoo, W., et al. (1998) · Current Biology · doi:10.1016/s0960-9822(07)00488-5 · Cited by 819 · see citing works

E-cadherin, β-catenin, and ZEB1 in malignant progression of cancer

Schmalhofer, O., Brabletz, S., & Brabletz, T. (2009) · Cancer and Metastasis Reviews · doi:10.1007/s10555-008-9179-y · Cited by 766 · see citing works

Ubiquitination regulates PTEN nuclear import and tumor suppression

Trotman, L. C., Wang, X., Alimonti, A., Chen, Z., Teruya-Feldstein, J., Yang, H., Pavletich, N. P., Carver, B. S., Cordon-Cardo, C., Erdjument-Bromage, H., et al. (2007) · Cell · doi:10.1016/j.cell.2006.11.040 · Cited by 748 · see citing works

Pten Dose Dictates Cancer Progression in the Prostate

Trotman, L. C., Niki, M., Dotan, Z., Koutcher, J. A., Cristofano, A. D., Xiao, A., Khoo, A. S. B., Roy‐Burman, P., Greenberg, N. M., Dyke, T. V., et al. (2003) · PLoS Biology · doi:10.1371/journal.pbio.0000059 · Cited by 677 · see citing works

Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer

Dinulescu, D. M., Ince, T. A., Quade, B. J., Shafer, S. A., Crowley, D. G., & Jacks, T. (2004) · Nature Medicine · doi:10.1038/nm1173 · Cited by 601 · see citing works

Deregulated Akt3 Activity Promotes Development of Malignant Melanoma

Stahl, J. M., Sharma, A. K., Cheung, M., Zimmerman, M., Cheng, J. Q., Bosenberg, M., KESTER, M. A., Sandirasegarane, L., & Robertson, G. P. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1399 · Cited by 595 · see citing works

Oncogenic Braf Induces Melanocyte Senescence and Melanoma in Mice

Dhomen, N. S., Reis-Filho, J. S., Dias, S. D. R., Hayward, R., Savage, K., Delmas, V., Larue, L., Pritchard, C. A., & Marais, R. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.02.022 · Cited by 590 · see citing works

Binding of Ras to Phosphoinositide 3-Kinase p110α Is Required for Ras- Driven Tumorigenesis in Mice

Gupta, S., Ramjaun, A. R., Haiko, P., Wang, Y., Warne, P. H., Nicke, B., Nye, E. L., Stamp, G., Alitalo, K. K., & Downward, J. (2007) · Cell · doi:10.1016/j.cell.2007.03.051 · Cited by 589 · see citing works

Malignant melanoma: genetics and therapeutics in the genomic eraPreprint

Chin, L., Garraway, L. A., & Fisher, D. E. (2006) · Genes & Development · doi:10.1101/gad.1437206 · Cited by 509 · see citing works

Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma.

Guldberg, P., Straten, P. T., Birck, A., Ahrenkiel, V., Kirkin, A. F., & Zeuthen, J. (1997) · PubMed · Cited by 480 · see citing works

PTEN signaling pathways in melanoma

Wu, H., Goel, V., & Haluska, F. G. (2003) · Oncogene · doi:10.1038/sj.onc.1206451 · Cited by 478 · see citing works

The Akt kinases: Isoform specificity in metabolism and cancer

Gonzalez, E., & McGraw, T. E. (2009) · Cell Cycle · doi:10.4161/cc.8.16.9335 · Cited by 478 · see citing works

Ras Isoforms Vary in Their Ability to Activate Raf-1 and Phosphoinositide 3-Kinase

Yan, J., Roy, S., Apolloni, A., Lane, A., & Hancock, J. F. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.37.24052 · Cited by 477 · see citing works

Genetic Interaction Between NRAS and BRAF Mutations and PTEN/MMAC1 Inactivation in Melanoma

Tsao, H., Yang, G., Goel, V., Wu, H., & Haluska, F. G. (2004) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2004.22243.x · Cited by 462 · see citing works

Classifying Melanocytic Tumors Based on DNA Copy Number Changes

Bastian, B. C., Olshen, A. B., LeBoit, P. E., & Pinkel, D. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63536-5 · Cited by 460 · see citing works

Overexpression of AKT2/protein kinase Bbeta leads to up-regulation of beta1 integrins, increased invasion, and metastasis of human breast and ovarian cancer cells.

Arboleda, M. J., Lyons, J. F., Kabbinavar, F. F., Bray, M. R., Snow, B. E., Ayala, R., Danino, M., Karlan, B. Y., & Slamon, D. J. (2003) · PubMed · Cited by 417 · see citing works

PTEN, more than the AKT pathway

Blanco‐Aparicio, C., Renner, O., Martínez-Leal, J. F., & Carnero, A. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm052 · Cited by 403 · see citing works

Cooperative effects of INK4a and ras in melanoma susceptibility in vivoPreprint

Chin, L., Pomerantz, J. H., Polsky, D., Jacobson, M., Cohen, C., Cordon‐Cardo, C., Horner, J. W., & DePinho, R. A. (1997) · Genes & Development · doi:10.1101/gad.11.21.2822 · Cited by 403 · see citing works

Comparative Oncogenomics Identifies NEDD9 as a Melanoma Metastasis Gene

Kim, M., Gans, J. D., Nogueira, C., Wang, A., Paik, J.-H., Feng, B., Brennan, C., Hahn, W. C., Cordon‐Cardo, C., Wagner, S. N., et al. (2006) · Cell · doi:10.1016/j.cell.2006.06.008 · Cited by 390 · see citing works

Examination of Mutations in BRAF, NRAS, and PTEN in Primary Cutaneous Melanoma

Goel, V., Lazar, A. J., Warneke, C. L., Redston, M. S., & Haluska, F. G. (2005) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700026 · Cited by 389 · see citing works

PTEN Interactions with Focal Adhesion Kinase and Suppression of the Extracellular Matrix-dependent Phosphatidylinositol 3-Kinase/Akt Cell Survival Pathway

Tamura, M., Gu, J., Danen, E. H. J., Takino, T., Miyamoto, S., & Yamada, K. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.29.20693 · Cited by 371 · see citing works

High incidence of breast and endometrial neoplasia resembling human Cowden syndrome in pten+/- mice.

Stambolic, V., Tsao, M., MacPherson, D. P., Suzuki, A., Chapman, W. B., & Mak, T. W. (2000) · PubMed · Cited by 353 · see citing works

Metastasizing Melanoma Formation Caused by Expression of Activated N-RasQ61K on an INK4a-Deficient Background

Ackermann, J., Frutschi, M., Kaloulis, K., McKee, T., Trumpp, A., & Beermann, F. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2970 · Cited by 308 · see citing works

Signal transduction from multiple Ras effectors

Katz, M. E., & McCormick, F. (1997) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(97)80112-8 · Cited by 299 · see citing works

Prostate intraepithelial neoplasia induced by prostate restricted Akt activation: The MPAKT model

Majumder, P., Yeh, J.-J., George, D., Febbo, P., Kum, J., Xue, Q., Bikoff, R., Ma, H.-K., Kantoff, P., Golub, T., et al. (2003) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.1232229100 · Cited by 299 · see citing works

Modeling Genomic Diversity and Tumor Dependency in Malignant Melanoma

Lin, W. M., Baker, A. C., Beroukhim, R., Winckler, W., Feng, W., Marmion, J. M., Laine, E., Greulich, H. E., Tseng, H., Gates, C., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2615 · Cited by 295 · see citing works

Epigenetic Silencing of the PTEN Gene in Melanoma

Mirmohammadsadegh, A., Marini, A., Nambiar, S., Hassan, M., Tannapfel, A., Ruzicka, T., & Hengge, U. R. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0384 · Cited by 279 · see citing works

A novel AKT3 mutation in melanoma tumours and cell lines

Davies, M. A., Stemke‐Hale, K., Tellez, C. S., Calderone, T. L., Deng, W., Prieto, V. G., Lazar, A. J., Gershenwald, J. E., & Mills, G. B. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604637 · Cited by 268 · see citing works

Constitutive activation of Akt/protein kinase B in melanoma leads to up-regulation of nuclear factor-kappaB and tumor progression.

Dhawan, P., Singh, A. B., Ellis, D. L., & Richmond, A. J. (2002) · PubMed · Cited by 255 · see citing works

Identification of PTEN/MMAC1 alterations in uncultured melanomas and melanoma cell lines

Tsao, H., Zhang, X., Benoit, E., & Haluska, F. G. (1998) · Oncogene · doi:10.1038/sj.onc.1201881 · Cited by 243 · see citing works

Loss of PTEN promotes tumor development in malignant melanoma.

Stahl, J. M., Cheung, M., Sharma, A. K., Trivedi, N. R., Shanmugam, S., & Robertson, G. P. (2003) · PubMed · Cited by 242 · see citing works

Relative reciprocity of NRAS and PTEN/MMAC1 alterations in cutaneous melanoma cell lines.

Tsao, H., Zhang, X., Fowlkes, K., & Haluska, F. G. (2000) · PubMed · Cited by 238 · see citing works

Akt1 Ablation Inhibits, whereas Akt2 Ablation Accelerates, the Development of Mammary Adenocarcinomas in Mouse Mammary Tumor Virus (MMTV)-ErbB2/Neu and MMTV-Polyoma Middle T Transgenic Mice

Maroulakou, I. G., Oemler, W., Naber, S. P., & Tsichlis, P. N. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3782 · Cited by 237 · see citing works

Compartmentalization of Ras proteins

Prior, I. A., & Hancock, J. F. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.9.1603 · Cited by 218 · see citing works

MicroRNAs Differentially Regulated by Akt Isoforms Control EMT and Stem Cell Renewal in Cancer Cells

Iliopoulos, D., Polytarchou, C., Hatziapostolou, M., Kottakis, F., Maroulakou, I. G., Struhl, K., & Tsichlis, P. N. (2009) · Science Signaling · doi:10.1126/scisignal.2000356 · Cited by 206 · see citing works

Targeted biallelic inactivation of Pten in the mouse prostate leads to prostate cancer accompanied by increased epithelial cell proliferation but not by reduced apoptosis.

Ma, X.-Q., der Made, A. C. J. Z.-V., Autar, B., van der Korput, H. A., Vermeij, M., van Duijn, P. V., Cleutjens, K., de Krijger, R. D., Krimpenfort, P., Berns, A., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4519 · Cited by 204 · see citing works

Mechanism of Akt1 inhibition of breast cancer cell invasion reveals a protumorigenic role for TSC2

Liu, H., Radisky, D. C., Nelson, C. M., Zhang, H., Fata, J. E., Roth, R. A., & Bissell, M. J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511342103 · Cited by 202 · see citing works

Melanoma genetics and the development of rational therapeutics

Chudnovsky, Y., Khavari, P. A., & Adams, A. E. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24808 · Cited by 202 · see citing works

Genetic Alterations in Signaling Pathways in Melanoma

Haluska, F. G., Tsao, H., Wu, H. L., Haluska, F. S., Lazar, A. J., & Goel, V. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2518 · Cited by 194 · see citing works

Use of human tissue to assess the oncogenic activity of melanoma-associated mutations

Chudnovsky, Y., Adams, A. E., Robbins, P. B., Lin, Q., & Khavari, P. A. (2005) · Nature Genetics · doi:10.1038/ng1586 · Cited by 193 · see citing works

Dual Inactivation of RB and p53 Pathways in RAS-Induced Melanomas

Bardeesy, N., Bastian, B. C., Hezel, A., Pinkel, D., DePinho, R. A., & Chin, L. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.6.2144-2153.2001 · Cited by 166 · see citing works

Melanocytic nevus-like hyperplasia and melanoma in transgenic BRAFV600E mice

Goel, V., Ibrahim, N., Jiang, G., Singhal, M., Fee, S., Flotte, T. J., Westmoreland, S. V., Haluska, F. S., Hinds, P. W., & Haluska, F. G. (2009) · Oncogene · doi:10.1038/onc.2009.95 · Cited by 165 · see citing works

PTEN Loss Accelerates Kras G12D -Induced Pancreatic Cancer Development

Hill, R., Calvopina, J. H., Kim, C. G., Wang, Y., Dawson, D. W., Donahue, T. R., Dry, S., & Wu, H. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1649 · Cited by 161 · see citing works

TGFβ-induced downregulation of E-cadherin-based cell-cell adhesion depends on PI3-kinase and PTEN

Vogelmann, R., Nguyen-tat, M.-D., Giehl, K., Adler, G., Wedlich, D., & Menke, A. (2005) · Journal of Cell Science · doi:10.1242/jcs.02594 · Cited by 159 · see citing works

Implication of the MAGI‐1b/PTEN signalosome in stabilization of adherens junctions and suppression of invasiveness

Kotelevets, L., van Hengel, J., Bruyneel, E. A., Mareel, M. M. K., Roy, F. M. V., & Chastre, E. (2004) · The FASEB Journal · doi:10.1096/fj.04-1942fje · Cited by 156 · see citing works

Genetic analysis of Pten and Ink4a/Arf interactions in the suppression of tumorigenesis in mice

You, M. J., Castrillón, D. H., Bastian, B. C., O’Hagan, R. C., Bosenberg, M., Parsons, R. E., Chin, L., & DePinho, R. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.022632099 · Cited by 144 · see citing works

The PTEN–AKT3 signaling cascade as a therapeutic target in melanoma

Madhunapantula, S. V., & Robertson, G. P. (2009) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2009.00585.x · Cited by 143 · see citing works

Mutation and Allelic Loss of the PTEN/MMAC1 gene in Primary and Metastatic Melanoma Biopsies

Birck, A., Ahrenkiel, V., Zeuthen, J., HOU-JENSEN, K., & Guldberg, P. (2000) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2000.00877.x · Cited by 142 · see citing works

Complementation of Hypopigmentation in p-Mutant (Pink-Eyed Dilution) Mouse Melanocytes by Normal Human P cDNA, and Defective Complementation by OCA2 Mutant Sequences

Sviderskaya, E. V., Bennett, D. C., Ho, L., Tu, B., Lee, S.-T., & Spritz, R. A. (1997) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12285621 · Cited by 119 · see citing works

Pten Inactivation Accelerates Oncogenic K-ras –Initiated Tumorigenesis in a Mouse Model of Lung Cancer

Iwanaga, K., Yang, Y., Raso, M. G., Ma, L., Hanna, A. E., Thilaganathan, N., Moghaddam, S. J., Evans, C. M., Li, H., Cai, W., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-3117 · Cited by 116 · see citing works

Both products of the mouse Ink4a/Arf locus suppress melanoma formation in vivo

Sharpless, N. E., Kannan, K., Xu, J., Bosenberg, M., & Chin, L. (2003) · Oncogene · doi:10.1038/sj.onc.1206809 · Cited by 97 · see citing works

Analysis ofras mutations in human melanocytic lesions: activation of theras gene seems to be associated with the nodular type of human malignant melanoma

Jafari, M., Papp, T., Kirchner, S., Kiener, U., Henschler, D., Burg, G., & Schiffmann, D. (1995) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf01202725 · Cited by 94 · see citing works

Methylation of PTEN as a Prognostic Factor in Malignant Melanoma of the Skin

Lahtz, C., Stranzenbach, R., Fiedler, E., Helmbold, P., & Dammann, R. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.226 · Cited by 83 · see citing works

A Mouse Model of Melanoma Driven by Oncogenic KRAS

Milagre, C. S., Dhomen, N. S., Geyer, F. C., Hayward, R., Lambros, M. B. K., Reis-Filho, J. S., & Marais, R. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4254 · Cited by 83 · see citing works

Somatic p16INK4a loss accelerates melanomagenesis

Monahan, K. B., Rozenberg, G. I., Krishnamurthy, J., Johnson, S. M., Liu, W., Bradford, M. K., Horner, J. W., DePinho, R. A., & Sharpless, N. E. (2010) · Oncogene · doi:10.1038/onc.2010.314 · Cited by 72 · see citing works

Role of Epidermal Growth Factor Receptor Signaling in RAS-Driven Melanoma

Bardeesy, N. M., Kim, M., Xu, J., Kim, R.-S., Shen, Q. “., Bosenberg, M., Wong, W. H., & Chin, L. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.10.4176-4188.2005 · Cited by 69 · see citing works

Differential oncogenic potential of activated RAS isoforms in melanocytes

Whitwam, T., VanBrocklin, M. W., Russo, M. E., Haak, P. T., Bilgili, D., Resau, J. H., Koo, H.-M., & Holmen, S. L. (2007) · Oncogene · doi:10.1038/sj.onc.1210239 · Cited by 69 · see citing works

AKT2 is a downstream target of metabotropic glutamate receptor 1 (Grm1)

Shin, S., Wall, B., Goydos, J. S., & Chen, S. (2009) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2009.00648.x · Cited by 46 · see citing works

PTEN Loss Promotes rasHa-Mediated Papillomatogenesis via Dual Up-Regulation of AKT Activity and Cell Cycle Deregulation but Malignant Conversion Proceeds via PTEN-Associated Pathways

Yao, D., Alexander, C. L., Quinn, J. A., Porter, M., Wu, H., & Greenhalgh, D. A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2341 · Cited by 29 · see citing works

Anticorresponding mutations of the KRAS and PTEN genes in human endometrial cancer.

Ikeda, T., Yoshinaga, K., Suzuki, A., Sakurada, A., Ohmori, H., & Horii, A. (2000) · Oncology Reports · doi:10.3892/or.7.3.567 · Cited by 28 · see citing works

Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma

Krauthammer, M., Kong, Y., Ha, B. H., Evans, P., Bacchiocchi, A., McCusker, J. P., Cheng, E., Davis, M. J., Goh, G., Choi, M., et al. (2012) · Nature Genetics · doi:10.1038/ng.2359 · Cited by 1,191 · see citing works

Lifetime Cancer Risks in Individuals with GermlinePTENMutations

Tan, M.-H., Mester, J. L., Ngeow, J. Y. Y., Rybicki, L. A., Orloff, M. S., & Eng, C. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2283 · Cited by 892 · see citing works

Cutaneous melanoma: From pathogenesis to therapy (Review)

Leonardi, G. C., Falzone, L., Salemi, R., Zanghì, A., Spandidos, D. A., McCubrey, J. A., Candido, S., & Libra, M. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4287 · Cited by 594 · see citing works

Signal pathways of melanoma and targeted therapy

Guo, W., Wang, H., & Li, C. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00827-6 · Cited by 403 · see citing works

The metabolic landscape of RAS-driven cancers from biology to therapy

Mukhopadhyay, S., Vander Heiden, M. G., & McCormick, F. (2021) · Nature Cancer · doi:10.1038/s43018-021-00184-x · Cited by 315 · see citing works

The YUMM lines: a series of congenic mouse melanoma cell lines with defined genetic alterations

Meeth, K. M., Wang, J. X., Micevic, G., Damsky, W., & Bosenberg, M. (2016) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12498 · Cited by 322 · see citing works

The Role of the PI3K-AKT Pathway in Melanoma

Davies, M. A. (2012) · The Cancer Journal · doi:10.1097/ppo.0b013e31824d448c · Cited by 240 · see citing works

Decoding Melanoma Metastasis

Damsky, W., Rosenbaum, L. E., & Bosenberg, M. (2010) · Cancers · doi:10.3390/cancers3010126 · Cited by 223 · see citing works

Directed migration of cancer cells guided by the graded texture of the underlying matrix

Park, J., Kim, D., Kim, H. N., Wang, C. J., Kwak, M. K., Hur, E., Suh, K. Y., An, S. S., & Levchenko, A. (2016) · Nature Materials · doi:10.1038/nmat4586 · Cited by 202 · see citing works

MiR-26a enhances metastasis potential of lung cancer cells via AKT pathway by targeting PTEN

Liu, B., Wu, X., Liu, B., Wang, C., Liu, Y., Zhou, Q., & Xu, K. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.07.019 · Cited by 184 · see citing works

RUNX2 and the PI3K/AKT axis reciprocal activation as a driving force for tumor progression

Cohen-Solal, K., Boregowda, R. K., & Lasfar, A. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0404-3 · Cited by 165 · see citing works

Aetiology and Pathogenesis of Cutaneous Melanoma: Current Concepts and Advances

Strashilov, S. A., & Yordanov, A. D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126395 · Cited by 169 · see citing works

Melanoma metastasis: new concepts and evolving paradigms

Damsky, W., Theodosakis, N., & Bosenberg, M. (2013) · Oncogene · doi:10.1038/onc.2013.194 · Cited by 163 · see citing works

Genetic alterations of PTEN in human melanoma

Aguissa-Touré, A.-H., & Li, G. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0878-0 · Cited by 161 · see citing works

AKT1 Activation Promotes Development of Melanoma Metastases

Cho, J. H., Robinson, J. P., Arave, R. A., Burnett, W. J., Kircher, D. A., Chen, G., Davies, M. A., Grossmann, A. H., VanBrocklin, M. W., McMahon, M., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.09.057 · Cited by 146 · see citing works

Recurrent hotspot mutations in HRAS Q61 and PI3K-AKT pathway genes as drivers of breast adenomyoepitheliomas

Geyer, F. C., Li, A., Papanastasiou, A. D., Smith, A. E., Selenica, P., Burke, K. A., Edelweiss, M., Wen, H., Piscuoglio, S., Schultheis, A. M., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04128-5 · Cited by 140 · see citing works

Cadherin switch from E- to N-cadherin in melanoma progression is regulated by the PI3K/PTEN pathway through Twist and Snail

Hao, L., Ha, J. R., Kuzel, P., Garcia, E., & Persad, S. (2012) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2012.10824.x · Cited by 135 · see citing works

The Importance of Being PI3K in the RAS Signaling Network

Cuesta, C., Arévalo-Alameda, C., & Castellano, E. (2021) · Genes · doi:10.3390/genes12071094 · Cited by 123 · see citing works

PTEN regulation of ERK1/2 signaling in cancer

Chetram, M. A., & Hinton, C. V. (2012) · Journal of Receptors and Signal Transduction · doi:10.3109/10799893.2012.695798 · Cited by 114 · see citing works

PTEN functions as a melanoma tumor suppressor by promoting host immune response

Dong, Y., Richards, J.-A., Gupta, R., Aung, P. P., Emley, A., Kluger, Y., Dogra, S. K., Mahalingam, M., & Wajapeyee, N. (2014) · Oncogene · doi:10.1038/onc.2013.409 · Cited by 113 · see citing works

Targeting the Akt Kinase to Modulate Survival, Invasiveness and Drug Resistance of Cancer Cells

Cassinelli, G., Zuco, V., Gatti, L., Lanzi, C., Zaffaroni, N., Colombo, D., & Perego, P. (2013) · Current Medicinal Chemistry · doi:10.2174/09298673113209990106 · Cited by 103 · see citing works

Navigating the Therapeutic Complexity of PI3K Pathway Inhibition in Melanoma

Kwong, L. N., & Davies, M. A. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0142 · Cited by 103 · see citing works

The Akt signaling pathway

Madhunapantula, S. V., Mosca, P. J., & Robertson, G. P. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.12.12.18442 · Cited by 96 · see citing works

Phytochemicals for the Management of Melanoma

Pal, H. C., Hunt, K. M., Diamond, A. C., Elmets, C. A., & Afaq, F. (2016) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557516666160211120157 · Cited by 87 · see citing works

Genetics of melanoma progression: the rise and fall of cell senescence

Bennett, D. C. (2015) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12422 · Cited by 88 · see citing works

Melanoma: Molecular genetics, metastasis, targeted therapies, immunotherapies, and therapeutic resistance

Wagstaff, W., Mwamba, R. N., Grullon, K., Armstrong, M. L., Zhao, P., Hendren-Santiago, B. K., Qin, K. H., Li, A. J., Hu, D. A., Youssef, A., et al. (2022) · Genes & Diseases · doi:10.1016/j.gendis.2022.04.004 · Cited by 85 · see citing works

BRAF/MAPK and GSK3 signaling converges to control MITF nuclear export

Ngeow, K. C., Friedrichsen, H. J., Li, L., Zeng, Z., Andrews, S., Volpon, L., Brunsdon, H., Berridge, G., Picaud, S., Fischer, R., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1810498115 · Cited by 82 · see citing works

Lipid metabolic Reprogramming: Role in Melanoma Progression and Therapeutic Perspectives

Pellerin, L., Carrié, L., Dufau, C., Nieto, L., Ségui, B., Levade, T., Riond, J., & Andrieu‐Abadie, N. (2020) · Cancers · doi:10.3390/cancers12113147 · Cited by 82 · see citing works

Cutaneous Melanoma: A Review of Multifactorial Pathogenesis, Immunohistochemistry, and Emerging Biomarkers for Early Detection and Management

Gosman, L. M., Țăpoi, D. A., & Costache, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115881 · Cited by 82 · see citing works

The Evolving Role of Radiation Therapy in the Management of Malignant Melanoma

Khan, N., Khan, M. K., Almasan, A., Singh, A. D., & Macklis, R. M. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.12.071 · Cited by 71 · see citing works

Differential AKT dependency displayed by mouse models of BRAFV600E-initiated melanoma

Durban, V. M., Deuker, M. M., Bosenberg, M., Phillips, W. A., & McMahon, M. (2013) · Journal of Clinical Investigation · doi:10.1172/jci69619 · Cited by 70 · see citing works

AKT1E17K Activates Focal Adhesion Kinase and Promotes Melanoma Brain Metastasis

Kircher, D. A., Trombetti, K. A., Silvis, M. R., Parkman, G. L., Fischer, G. M., Angel, S. N., Stehn, C. M., Strain, S. C., Grossmann, A. H., Duffy, K. L., et al. (2019) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-1372 · Cited by 69 · see citing works

WNT/β-catenin signaling regulates mitochondrial activity to alter the oncogenic potential of melanoma in a PTEN-dependent manner

Brown, K., Yang, P., Salvador, D., Kulikauskas, R. M., Ruohola‐Baker, H., Robitaille, A. M., Chien, A. J., Moon, R. T., & Sherwood, V. (2017) · Oncogene · doi:10.1038/onc.2016.450 · Cited by 65 · see citing works

The transcription factor ATF2 promotes melanoma metastasis by suppressing protein fucosylation

Lau, E. K., Feng, Y., Claps, G., Fukuda, M. N., Perlina, A., Donn, D., Jilaveanu, L. B., Kluger, H. M., Freeze, H. H., & Ronai, Z. A. (2015) · Science Signaling · doi:10.1126/scisignal.aac6479 · Cited by 62 · see citing works

Melanoma therapeutics: a literature review

Dhanyamraju, P. K., & Patel, T. (2022) · Journal of Biomedical Research · doi:10.7555/jbr.36.20210163 · Cited by 61 · see citing works

Future of radiation therapy for malignant melanoma in an era of newer, more effective biological agents

Khan, M. K., & Almasan, A. (2011) · OncoTargets and Therapy · doi:10.2147/ott.s20257 · Cited by 60 · see citing works

Glutamatergic signaling in cellular transformation

Teh, J. L. F., & Chen, S. (2012) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2012.00983.x · Cited by 59 · see citing works

Combined analysis of KRAS and PIK3CA mutations, MET and PTEN expression in primary tumors and corresponding metastases in colorectal cancer

Voutsina, A., Tzardi, M. N., Kalikaki, A., Zafeiriou, Z., Papadimitraki, E., Papadakis, M., Mavroudis, D., & Georgoulias, V. (2012) · Modern Pathology · doi:10.1038/modpathol.2012.150 · Cited by 55 · see citing works

A Tumor Suppressor Function for the Lipid Phosphatase INPP4B in Melanocytic Neoplasms

Pérez‐Lorenzo, R., Gill, K. Z., Shen, C., Zhao, F., Zheng, B., Schulze, H.-J., Silvers, D. N., Brunner, G., & Horst, B. A. J. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.511 · Cited by 55 · see citing works

Chemotherapy-Induced Depletion of OCT4-Positive Cancer Stem Cells in a Mouse Model of Malignant Testicular Cancer

Pierpont, T. M., Lyndaker, A. M., Anderson, C. M., Jin, Q., Moore, E. S., Roden, J., Braxton, A. M., Bagepalli, L., Kataria, N., Hu, H. Z., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.10.078 · Cited by 55 · see citing works

Born to be Alive: A Role for the BCL-2 Family in Melanoma Tumor Cell Survival, Apoptosis, and Treatment

Anvekar, R. A., Asciolla, J. J., Missert, D. J., & Chipuk, J. E. (2011) · Frontiers in Oncology · doi:10.3389/fonc.2011.00034 · Cited by 55 · see citing works

N-cadherin regulates mammary tumor cell migration through Akt3 suppression

Chung, S., Yao, J., Suyama, K., Bajaj, S., Qian, X., Loudig, O. D., Eugenín, E. A., Phillips, G. R., & Hazan, R. B. (2012) · Oncogene · doi:10.1038/onc.2012.65 · Cited by 54 · see citing works

Ceramide Kinase Inhibition Drives Ferroptosis and Sensitivity to Cisplatin in Mutant KRAS Lung Cancer by Dysregulating VDAC-Mediated Mitochondria Function

Vu, N., Kim, M., Stephenson, D., MacKnight, H. P., & Chalfant, C. E. (2022) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-22-0085 · Cited by 51 · see citing works

Targeting sphingosine kinase‐1 to inhibit melanoma

Madhunapantula, S. V., Hengst, J. A., Gowda, R., Fox, T. E., Yun, J. K., & Robertson, G. P. (2012) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2012.00970.x · Cited by 52 · see citing works

Therapeutic Implications of Targeting AKT Signaling in Melanoma

Madhunapantula, S. V., & Robertson, G. P. (2011) · Enzyme Research · doi:10.4061/2011/327923 · Cited by 52 · see citing works

Modelling melanoma in mice

Walker, G. J., Soyer, H. P., Terzian, T., & Box, N. F. (2011) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2011.00923.x · Cited by 49 · see citing works

A Phosphatidylinositol 3-Kinase–Pax3 Axis Regulates Brn-2 Expression in Melanoma

Bonvin, E., Falletta, P., Shaw, H. M., Delmas, V., & Goding, C. R. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.01067-12 · Cited by 48 · see citing works

MicroRNA-28 promotes cell proliferation and invasion in gastric cancer via the PTEN/PI3K/AKT signalling pathway

Li, L., Zhu, X., Shou, T., Yang, L., Cheng, X., Wang, J., Deng, L., & Zheng, Y. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.8299 · Cited by 48 · see citing works

Current understanding of epigenetics role in melanoma treatment and resistance

Fath, M. K., Azargoonjahromi, A., Soofi, A., Almasi, F., Hosseinzadeh, S., Khalili, S., Sheikhi, K., Ferdousmakan, S., Owrangi, S., Fahimi, M., et al. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02738-0 · Cited by 50 · see citing works

Active β-catenin is regulated by the PTEN/PI3 kinase pathway: a role for protein phosphatase PP2A

Persad, A. R. L., Venkateswaran, G., Li, H., Garcia, M. E., Yoon, J., Sidhu, J., & Persad, S. (2017) · Genes & Cancer · doi:10.18632/genesandcancer.128 · Cited by 45 · see citing works

Functional Effects of GRM1 Suppression in Human Melanoma Cells

Wangari-Talbot, J., Wall, B., Goydos, J. S., & Chen, S. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0158 · Cited by 46 · see citing works

Multifaceted Regulation of PTEN Subcellular Distributions and Biological Functions

Liu, T., Wang, Y., Wang, Y., & Chan, A. M.-L. (2019) · Cancers · doi:10.3390/cancers11091247 · Cited by 40 · see citing works

High-expression of DJ-1 and Loss of PTEN Associated with Tumor Metastasis and Correlated with Poor Prognosis of Gastric Carcinoma

Li, Y., Cui, J., Zhang, C., Yang, D., Chen, J., Zhan, W.-H., Li, B., Li, Z., & He, Y. (2013) · International Journal of Medical Sciences · doi:10.7150/ijms.7292 · Cited by 40 · see citing works

PTEN and Melanomagenesis

Conde‐Perez, A., & Larue, L. (2012) · Future Oncology · doi:10.2217/fon.12.106 · Cited by 37 · see citing works

Advances in melanoma senescence and potential clinical application

Giuliano, S., Ohanna, M., Ballotti, R., & Bertolotto, C. (2010) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2010.00820.x · Cited by 34 · see citing works

Metabotropic glutamate receptors and cancerous growth

Teh, J. L. F., & Chen, S. (2011) · Wiley Interdisciplinary Reviews Membrane Transport and Signalling · doi:10.1002/wmts.21 · Cited by 33 · see citing works

Genetics of melanoma

Wangari‐Talbot, J., & Chen, S. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2012.00330 · Cited by 33 · see citing works

Defining the Tumor Microenvironment by Integration of Immunohistochemistry and Extracellular Matrix Targeted Imaging Mass Spectrometry

Rujchanarong, D., Lefler, J. E., Saunders, J. E., Pippin, S., Spruill, L., Bethard, J. R., Ball, L. E., Mehta, A. S., Drake, R. R., Ostrowski, M. C., et al. (2021) · Cancers · doi:10.3390/cancers13174419 · Cited by 31 · see citing works

Animal models of melanoma: a somatic cell gene delivery mouse model allows rapid evaluation of genes implicated in human melanoma

McKinney, A. J., & Holmen, S. L. (2011) · 癌症：英文版 · doi:10.5732/cjc.011.10007 · Cited by 31 · see citing works

Non-pungent long chain capsaicin-analogs arvanil and olvanil display better anti-invasive activity than capsaicin in human small cell lung cancers

Hurley, J. D., Akers, A. T., Friedman, J. R., Nolan, N. A., Brown, K. C., & Dasgupta, P. (2016) · Cell Adhesion & Migration · doi:10.1080/19336918.2016.1187368 · Cited by 31 · see citing works

The transcription factor RUNX2 regulates receptor tyrosine kinase expression in melanoma

Boregowda, R. K., Medina, D. J., Markert, E. K., Bryan, M. A., Chen, W., Chen, S., Rabkin, A., Vido, M. J., Gunderson, S., Chekmareva, M. A., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8822 · Cited by 29 · see citing works

A majority of human melanoma cell lines exhibits an S phase-specific defect in excision of UV-induced DNA photoproducts

Bélanger, F., Rajotte, V., & Drobetsky, E. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085294 · Cited by 29 · see citing works

Mouse melanoma models and cell lines

Damsky, W., & Bosenberg, M. (2010) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2010.00777.x · Cited by 28 · see citing works

Targeting protein kinase-b3 (akt3) signaling in melanoma

Madhunapantula, S. V., & Robertson, G. P. (2017) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2017.1279147 · Cited by 25 · see citing works

TBX2 controls a proproliferative gene expression program in melanomaPreprint

Lu, S., Louphrasitthiphol, P., Goradia, N., Lambert, J., Schmidt, J., Chauhan, J. S., Rughani, M. G., Larue, L., Wilmanns, M., & Goding, C. R. (2021) · Genes & Development · doi:10.1101/gad.348746.121 · Cited by 21 · see citing works

Chromosome 10, Frequently Lost in Human Melanoma, Encodes Multiple Tumor-Suppressive Functions

Kwong, L. N., & Chin, L. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-1446 · Cited by 22 · see citing works

Human relevance of NRAS/BRAF mouse melanoma models

Conde‐Perez, A., & Larue, L. (2013) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2013.10.010 · Cited by 22 · see citing works

The Role of Senescent Cells in Acquired Drug Resistance and Secondary Cancer in BRAFi-Treated Melanoma

Thompson, E. L., Hu, J., & Niedernhofer, L. J. (2021) · Cancers · doi:10.3390/cancers13092241 · Cited by 19 · see citing works

Microrna-136 promotes proliferation and invasion ingastric cancer cells through Pten/Akt/P-Akt signaling pathway

Chen, X., Huang, Z., & Chen, R. (2018) · Oncology Letters · doi:10.3892/ol.2018.7848 · Cited by 20 · see citing works

Obesity and melanoma: Exploring molecular links

Chen, J., Chi, M., Chen, C., & Zhang, X. D. (2013) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24549 · Cited by 20 · see citing works

Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas

Manca, A., Lissia, A., Capone, M., Ascierto, P. A., Botti, G., Caracò, C., Stanganelli, I., Colombino, M., Sini, M. C., Cossu, A., et al. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0401-8 · Cited by 18 · see citing works

Metabotropic glutamate receptor 1 mediates melanocyte transformation via transactivation of insulin‐like growth factor 1 receptor

Teh, J. L. F., Shah, R., Shin, S., Wen, Y., Mehnert, J. M., Goydos, J. S., & Chen, S. (2014) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12237 · Cited by 16 · see citing works

Glutamatergic Signaling a Therapeutic Vulnerability in Melanoma

Eddy, K., & Chen, S. (2021) · Cancers · doi:10.3390/cancers13153874 · Cited by 15 · see citing works

PLEKHA5: A Key to Unlock the Blood–Brain Barrier?

Eisele, S. C., Gill, C. M., Shankar, G. M., & Brastianos, P. K. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2604 · Cited by 14 · see citing works

Cooperative interactions of PTEN deficiency and RAS activation in melanoma metastasis

Kim, M. (2010) · Small GTPases · doi:10.4161/sgtp.1.3.14344 · Cited by 14 · see citing works

Cooperative function of oncogenic MAPK signaling and the loss of Pten for melanoma migration through the formation of lamellipodia

Yasuta, Y., Kaminaka, R., Nagai, S., Mouri, S., Ishida, K., Tanaka, A., Zhou, Y., Sakurai, H., & Yokoyama, S. (2024) · Scientific Reports · doi:10.1038/s41598-024-52020-8 · Cited by 12 · see citing works

Current Management of Malignant Melanoma: State of the Art

Kutlubay, Z., Engіn, B., Serdaroğlu, S., & Tuzu, Y. (2013) · InTech eBooks · doi:10.5772/55304 · Cited by 9 · see citing works

The PI3K-AKT Pathway in Melanoma

Siroy, A. E., Davies, M. A., & Lazar, A. J. (2016) · Springer eBooks · doi:10.1007/978-1-4939-3554-3_7 · Cited by 8 · see citing works

Molecular Biology and Genetic Mechanisms in the Progression of the Malignant Skin Melanoma

Pejkova, S., Dzokic, G., Tudzarova-Gjorgova, S., & Панов, С. (2016) · PRILOZI · doi:10.1515/prilozi-2016-0021 · Cited by 8 · see citing works

AKT2 Loss Impairs BRAF-Mutant Melanoma Metastasis

McRee, S. K., Bayer, A. L., Pietruska, J. R., Tsichlis, P. N., & Hinds, P. W. (2023) · Cancers · doi:10.3390/cancers15204958 · Cited by 8 · see citing works

The Roles of PTEN in Melanoma Suppression

Parkman, G. L., Xu, X., Holmen, S. L., & Karreth, F. A. (2025) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.70054 · Cited by 7 · see citing works

Taking stock of translational research in melanoma at the 2010 Society for Melanoma Research Congress

Flaherty, K. T. (2010) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2010.00816.x · Cited by 7 · see citing works

Combination of chemotherapy with BRAF inhibitors results in effective eradication of malignant melanoma by preventing ATM-dependent DNA repair

Alonso‐Marañón, J., Villanueva, A., Piulats, J. M., Martínez‐Iniesta, M., Solé, L., Martín-Liberal, J., Segura, S., Pujol, R. M., Iglesias, M., Bigas, A., et al. (2021) · Oncogene · doi:10.1038/s41388-021-01879-2 · Cited by 7 · see citing works

Refining mutanome-based individualised immunotherapy of melanoma using artificial intelligence

Zakariya, F., Salem, F. K., Alamrain, A. A., Sanker, V., Abdelazeem, Z. G., Hosameldin, M., Tan, J. K., Howard, R., Huang, H. Y. R., & Awuah, W. A. (2024) · European journal of medical research · doi:10.1186/s40001-023-01625-2 · Cited by 6 · see citing works

An Experimental Protocol for the Boyden Chamber Invasion Assay With Absorbance Readout

Brown, K. C., Sugrue, A. M., Modi, K. J., Light, R. S., Conley, K. B., Cox, A. J., Bender, C. R., Miles, S. L., Valentovic, M. A., & Dasgupta, P. (2024) · BIO-PROTOCOL · doi:10.21769/bioprotoc.5040 · Cited by 5 · see citing works

Cancer stem cells, plasticity, and drug resistance

Lionetti, M. C., Fumagalli, M. R., & Porta, C. A. M. L. (2020) · Cancer Drug Resistance · doi:10.20517/cdr.2019.112 · Cited by 6 · see citing works

Skin, Hair, and Nails

Sundberg, J. P., King, L. E., & Kuiper, R. (2021) · Wiley eBooks · doi:10.1002/9781119624608.ch10 · Cited by 4 · see citing works

Federated SPARQL query performance evaluation for exploring disease model mouse: combining gene expression, orthology, and disease knowledge graphs

Kushida, T., de Farias, T. M., Sima, A. C., Dessimoz, C., Chiba, H., Bastian, F., & Masuya, H. (2025) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-025-03013-8 · Cited by 2 · see citing works

Pathophysiology roles and translational opportunities of miRNAs in cutaneous melanoma

Ferracin, M., Broseghini, E., & Dika, E. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-822287-4.00022-0 · Cited by 2 · see citing works

Exploring Disease Model Mouse Using Knowledge Graphs: Combining Gene Expression, Orthology, and Disease DatasetsPreprint

Kushida, T., de Farias, T. M., Sima, A. C., Dessimoz, C., Chiba, H., Bastian, F., & Masuya, H. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.30.555283 · Cited by 2 · see citing works

Actionable Mutation Profile of Sun-Protected Melanomas in South America

Hsieh, R., Nico, M. M. S., Coutinho‐Camillo, C. M., Oliveira, K. K., Carraro, D. M., Sangüeza, M., & Lourenço, S. V. (2022) · American Journal of Dermatopathology · doi:10.1097/dad.0000000000002213 · Cited by 1 · see citing works

Understanding Melanocyte Transformation – A Work in Progress

Wangari‐Talbot, J., Goydos, J. S., & Che, S. (2011) · InTech eBooks · doi:10.5772/19753 · Cited by 1 · see citing works

Impact of circRNA on the complex regulatory network of the cell

Porta, C. A. M. L. (2019) · Non-coding RNA Investigation · doi:10.21037/ncri.2019.05.01 · Cited by 1 · see citing works

Signaling Networks that Induce Melanomagenesis and Metastasis that can be Exploited for Therapeutic Benefit

Tanzosh, E. E. (2013)

Role of checkpoint kinase 1 in malignant melanoma

Smith, J. (2013) · Enlighten: Theses (The University of Glasgow)

Skin Diseases-Related Enzymes: Mechanisms and Clinical Applications

Park, Y., Yang, J., & Lü, Z.-R. (2011) · Enzyme Research · doi:10.4061/2011/464507

New Approaches to Signaling

Sullivan, R., & Flaherty, K. (2017) · Springer eBooks · doi:10.1007/978-3-319-41319-8_16

Parallel and Serial Blockade Strategies in BRAF-Mutant Melanoma

Davies, M. A. (2014) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-1-4939-2143-0_6

Regulation of ERK1/2 signaling in melanoma

Haydn, J. M. (2012)

Cooperative interactions of PTEN deficiency and RAS activation in melanoma metastasis. Oncogene 47: 6222–6232

Nogueira, C., Kim, K.-H., Sung, H., Paraiso, K. H. T., Bosenberg, M., Chin, L., & Kim, M. (2010)

Abstract LB-154: Loss of PTEN cooperates with activated RAS in melanoma genesis and progression

Nogueira, C., Kim, K., Paraiso, K. H. T., Dannenberg, J., Bosenberg, M., Chin, L., & Kim, M. (2010) · Cancer Research · doi:10.1158/1538-7445.am10-lb-154

Relative reciprocity of NRAS and PTEN/MMAC1 alterations in cutaneous melanoma cell lines.

Tsao, H., Zhang, X., Fowlkes, K., & Haluska, F. G. (2000) · PubMed · Cited by 238 · see citing works

Genetic Interaction Between NRAS and BRAF Mutations and PTEN/MMAC1 Inactivation in Melanoma

Tsao, H., Yang, G., Goel, V., Wu, H., & Haluska, F. G. (2004) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2004.22243.x · Cited by 462 · see citing works

Abstract 1446: Dissecting the role of PTEN/Akts in metastatic melanoma

Yu, Y., Liu, Z., Yu, Y., Mendoza, A., Khanna, C., & Merlino, G. T. (2011) · Cancer Research · doi:10.1158/1538-7445.am2011-1446